person

Angelica F.

Country
Spain
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 13 partner sites.

Specializations

Solid Tumor Oncology

Angelica Ferrando focuses on therapeutic advances for major solid tumors in advanced or metastatic settings.

  • Breast cancer
  • Non‑Small Cell Lung Cancer
  • Colorectal cancer
  • Gastric adenocarcinoma
  • Ovarian cancer

The work emphasizes treatment options for unresectable disease and biomarker‑selected subgroups.

Hematologic Malignancies

Ferrando’s research portfolio includes a broad range of hematologic cancers, targeting both lymphoid and myeloid disorders.

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma
  • Diffuse Large B‑Cell Lymphoma

These studies address relapsed, refractory, and high‑risk disease phenotypes.

Targeted and Immuno‑Oncology Therapies

The investigator explores novel targeted agents and immune‑based therapies across cancer types.

  • HER2‑positive tumors
  • KRAS G12C‑mutated cancers
  • PD‑L1‑expressing malignancies
  • BRCA‑mutated breast and ovarian cancers
  • ALK‑positive lung cancer

Efforts aim to integrate precision biomarkers with therapeutic decision‑making.

Rare and Specialized Oncology

Ferrando also leads investigations into less common rare cancers and disease subsets.

  • Uveal melanoma
  • Neuroendocrine tumors
  • Soft‑tissue sarcomas
  • Primary mediastinal large B‑cell lymphoma
  • Hepatocellular carcinoma

These projects address therapeutic gaps in orphan indications.

Precision Medicine and Biomarker‑Driven Trials

Across her portfolio, Ferrando prioritizes precision oncology by matching therapies to molecular alterations.

  • BRCA1/2 mutations
  • IDH1‑mutant leukemias
  • PIK3CA‑mutated breast cancer
  • FGFR2b‑positive gastric cancers
  • MSI‑high/dMMR colorectal cancers

These initiatives seek to improve outcomes through genotype‑guided treatment strategies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.